Clinical Trial Update: Trial Evaluating Three Fixed Doses of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With Schizophrenia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating three fixed doses of paliperidone extended-release (ER) tablets in combination with olanzapine for schizophrenia has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Paliperidone Extended Release (paliperidone extended-release)
• olanzapine (olanzapine)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED